<DOC>
	<DOCNO>NCT02424344</DOCNO>
	<brief_summary>The present study plan evaluate effect aclidinium bromide/formoterol fumarate 400/12 μg FDC BID hyperinflation , exercise endurance physical activity patient moderate severe COPD . Additionally , effect behavioural intervention top aclidinium bromide/formoterol fumarate 400/12 μg assess exercise endurance physical activity .</brief_summary>
	<brief_title>EFFECT OF ACLIDINIUM/FORMOTEROL ON LUNG HYPERINFLATION , EXERCICE CAPACITY AND PHYSICAL ACTIVITY IN MODERATE TO SEVERE COPD PATIENTS</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Bromides</mesh_term>
	<criteria>1 . Males nonpregnant , nonlactating female age ≥ 40 . 2 . Patients clinical diagnosis COPD accord GOLD guideline 2014 , post bronchodilator FEV1 ≥ 40 % &lt; 80 % predict value FEV1/FVC &lt; 70 % Visit 1 . 3 . Functional residual capacity ( FRC ) measure body plethysmography Visit 1 ≥ 120 % predict value . 4 . Patients modify Medical Research Council dyspnea scale ( mMRC ) ≥ 2 Visit 1 . 5 . Current former cigarette smoker smoke history least 10 packyears Visit 1 6 . Patients willing participate telecoaching program four last week enhance physical activity 7 . Patients understand able follow study procedure , cooperative willing participate study indicate sign informed consent . 1 . History current diagnosis asthma . 2 . Any respiratory tract infection ( include upper respiratory tract ) COPD exacerbation 6 week prior Visit 1 runin period . 3 . Patients hospitalise acute COPD exacerbation within 3 month prior Visit 1 runin period . 4 . Clinically significant respiratory condition COPD . 5 . Use longterm oxygen therapy ( ≥ 15 hours/day ) . 6 . Oxygen saturation ≤ 85 % measure pulse oximetry exercise test Visit 1 , Visit 2 Visit 3 prior randomisation . 7 . Patients Body Mass Index ( BMI ) ≥ 40kg/m2 . 8 . Patient may need start pulmonary rehabilitation program study and/or started/finished within 3 month prior Visit 1 runin period . 9 . Patients clinically significant cardiovascular condition . 10 . Patients Type I uncontrolled Type II diabetes , uncontrolled hypoor hyperthyroidism , hypokalaemia , hyperadrenergic state , uncontrolled untreated hypertension . 11 . Patient know noncontrolled history infection human immunodeficiency virus ( HIV ) and/or active hepatitis . 12 . Patients clinically relevant abnormality result blood pressure , ECG , physical examination Visit 1 . 13 . Patients serious uncontrolled physical mental dysfunction could place patient high risk derive his/her participation study could confound result 14 . Patients condition COPD may contribute dyspnoea exercise limitation contraindication clinical exercise test accord ATS recommendation CPET 15 . Patients relevant comorbidities make patient suitable followup study procedure and/or could affect physical activity 16 . Patients cycle &lt; 2 minute &gt; 15 minute constant workrate exercise test conduct Visit 2 ( Runin Visit ) Visit 3 even adjustment work load . 17 . Patients history hypersensitivity reaction inhale anticholinergic , sympathomimetic amine inhale medication component thereof ( include report paradoxical bronchospasm ) 18 . Patients use anticholinergic drug contraindicate ( acute urinary retention , symptomatic prostatic hypertrophy , bladder neck obstruction narrowangle glaucoma ) 19 . Patients unable properly use multidose dry powder inhaler pressurize metereddose inhaler ( pMDI ) . 20 . Patients use prohibited medication ( include IMP within 30 day ( 6 halflives , whichever long ) Visit 1 ) undergone require washout period . 21 . History malignancy organ system ( include lung cancer ) , treat untreated , within past 5 year basal squamous cell skin cancer ) . 22 . Patients maintain regular day/night , waking/sleeping cycle ( e.g. , night shift worker , sleep apnea ) . 23 . Patients unable give consent , patient consent age guardianship , vulnerable patient</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>130 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>COPD</keyword>
</DOC>